Phase II trial of ixabepilone (Ixa) and dasatinib (D) for treatment of metastatic breast cancer (MBC)

Authors
Category Primary study
JournalCANCER RESEARCH
Year 2012
This article has no abstract
Epistemonikos ID: 825b7d65c705e1ff6faf2f895c0807d0616710cf
First added on: Feb 05, 2025